nine children with poor-prognosis malignancies -- seven with advanced neuroblastoma and two with metastatic ewing 's sarcoma -- were given high doses of melphalan ( hdm ) , 150 mg/m2 ( 3 patients ) and 180 mg/m2 ( 6 patients ) , as a 'late intensification ' agent combined with noncryopreserved autologous bone marrow transplants .
C0027819
neuroblastoma
C0025241
melphalan